MUPIROCIN
- Product NDC
- 45802-018
- 11-digit product format
- 458020018
- Labeler code
- 45802
- Product ID
- 45802-018_47e0d0f4-82cd-4899-b67b-63224f8f7db6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- mupirocin
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Application
- ANDA212465
- Marketing category
- ANDA
- Marketing start
- 2022-09-06
- Marketing end
- 0000-00-00
- Substance
- MUPIROCIN CALCIUM
- Active strength
- 20 mg/g
- Pharmacologic classes
- RNA Synthetase Inhibitor Antibacterial [EPC], RNA Synthetase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45802-018-14 | 45802001814 | 1 TUBE in 1 CARTON (45802-018-14) > 15 g in 1 TUBE | 1 tube | 2022-09-06 | 0000-00-00 | No | No | Current |
| 45802-018-94 | 45802001894 | 1 TUBE in 1 CARTON (45802-018-94) > 30 g in 1 TUBE | 1 tube | 2022-09-06 | 0000-00-00 | No | No | Current |